For the quarter ending 2026-03-31, JXN had -$165M decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) | -420 | -186 | 91 | 167 |
| Net realized losses (gains) on investments | -47 | -5 | 64 | -175 |
| Net losses (gains) on derivatives | 330 | -703 | -1,196 | -1,342 |
| Net losses (gains) on funds withheld reinsurance treaties | -159 | -210 | -379 | -715 |
| Net (gain) loss on market risk benefits | -1,670 | -788 | 226 | -43 |
| (gain) loss from updating future policy benefits cash flow assumptions, net | -18 | -7 | -13 | -24 |
| Interest credited on other contract holder funds, gross | 315 | 325 | 313 | 583 |
| Mortality, expense and surrender charges | 127 | 128 | 130 | 263 |
| Amortization of discount and premium on investments | 14 | 7 | 14 | 18 |
| Deferred income tax expense (benefit) | 19 | -169 | 3 | -7 |
| Share-based compensation | 60 | 26 | 34 | 72 |
| Accrued investment income | 2 | 49 | 24 | 32 |
| Deferred acquisition costs | -26 | 6 | -27 | -206 |
| Funds withheld, net of reinsurance | -120 | -8 | 60 | -168 |
| Future policy benefits | 129 | 25 | 119 | 277 |
| Other assets and liabilities, net | 367 | -119 | 49 | 131 |
| Net cash provided by (used in) operating activities | 1,045 | 1,621 | 1,370 | 2,767 |
| Proceeds From Sale And Maturity Of | 2,353 | 2,087 | 2,235 | 4,091 |
| Proceeds From Sale Of | 16 | 0 | 27 | 19 |
| Proceeds From Sale And Collection Of | 463 | 493 | 418 | 730 |
| Payments To Acquire | 4,009 | 3,526 | 4,257 | 6,758 |
| Payments To Acquire | 0 | 0 | 21 | 0 |
| Payments To Acquire | 724 | 783 | 416 | 751 |
| Settlements related to derivatives and collateral on investments | 471 | 129 | 49 | 928 |
| Other investing activities | 58 | 86 | 31 | 121 |
| Net cash provided by (used in) investing activities | -2,430 | -1,944 | -2,094 | -3,718 |
| Deposits | 7,334 | 7,595 | 7,634 | 12,126 |
| Withdrawals | 11,187 | 11,821 | 11,071 | 19,353 |
| Net transfers from (to) separate accounts | 5,402 | 6,045 | 5,251 | 9,465 |
| Proceeds from (payments on) repurchase agreements and securities lending | -531 | 4 | -137 | -383 |
| Net proceeds from (payments on) federal home loan bank notes | 0 | 0 | 0 | 700 |
| Settlements related to deferred premium on derivatives | -154 | 121 | -7 | - |
| Payments on debt | 4 | 0 | 1 | 4 |
| Pre-capitalized trust securities issuance costs | 7 | - | - | - |
| Issuance of debt of consolidated investment entities | 96 | 242 | 99 | 395 |
| Repayments of debt of consolidated investment entities | 35 | 375 | 54 | 98 |
| Contributions from partners of consolidated investments | 108 | 99 | 10 | 17 |
| Distributions from partners of consolidated investments | - | 0 | 0 | - |
| Dividends on common stock | 64 | 54 | 54 | 115 |
| Dividends on preferred stock | 11 | 11 | 11 | 22 |
| Purchase of treasury stock | 227 | 152 | 157 | 360 |
| Issuance of preferred stock | - | 0 | - | - |
| Issuance of treasury stock | 500 | - | - | - |
| Net cash provided by (used in) financing activities | 1,220 | 1,465 | 1,502 | 968 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | -165 | 1,142 | 778 | 17 |
| Cash, cash equivalents, and restricted cash at beginning of period | 5,704 | 4,562 | 3,767 | - |
| Total cash, cash equivalents, and restricted cash at end of period | 5,539 | 5,704 | 4,562 | - |
Jackson Financial Inc. (JXN)
Jackson Financial Inc. (JXN)